Comparison · NCT00524472-3193d1fe
Hyperinsulinemic-normoglycemic Clamp vs Insulin at the Standard of Care Levels: Any Major Morbidity/30-day Mortality
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Hyperinsulinemic-normoglycemic Clamp vs Insulin at the Standard of Care Levels: Any Major Morbidity/30-day Mortality. Trial comparisons, record NCT00524472-3193d1fe. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00524472-3193d1fe
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0649 | 0.049 | 0.0855 | wilson | |
| Risk in group 2 | 0.112 | 0.0914 | 0.137 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0474 | -0.077 | -0.0181 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.578 | 0.409 | 0.816 | log | |
| Odds ratio, group 1 over group 2 | 0.548 | 0.376 | 0.799 | log | |
| Number needed to treat, for one fewer participant with the outcome on Hyperinsulinemic-normoglycemic Clamp than on Insulin at the Standard of Care Levels | 21.1 | 13 | 55.2 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: standard of care.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Hyperinsulinemic-normoglycemic Clamp | Patients will be randomized to receive the hyperinsulinemic-normoglycemic clamp titrating the blood glucose to 80-110 mg/dL.~Hyperinsulinemic-normoglycemic clamp: Patients will be randomized to receive the hyperinsulinemic-normoglycemic clamp titrating the blood glucose to 80-110 mg/dL. | 46 | 709 | OG000 |
| Group 2 | Insulin at the Standard of Care Levels | Group B will be administered insulin at the standard of care levels established by the participating institution.~insulin at the standard of care levels: Subjects will be administered insulin at the standard of care levels established by the participating institution. | 82 | 730 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Any Major Morbidity/30-day Mortality
- Description
a composite (any versus none) of the following major postoperative complications occurring:~1. all-cause postoperative mortality~2. failure to wean from cardiopulmonary bypass or postoperative low cardiac index requiring mechanical circulatory support with intraaortic balloon counterpulsation, ventricular assist device, and/or extracorporeal mechanical oxygenation~3. serious postoperative infection~4. acute postoperative kidney injury requiring renal replacement therapy;~5. new postoperative focal or global neurologic deficit.
- Time frame
- within 30 days post surgery
- Population
Source ClinicalTrials.gov
Trial
- Title
- Outcomes Study of Hyperinsulinemic Glucose Control in Cardiac Surgery
- NCT number
- NCT00524472
- Phases
- NA
- Conditions
- Cardiac Surgery
- Interventions
- Hyperinsulinemic-normoglycemic clamp, insulin at the standard of care levels
- Lead sponsor
- The Cleveland Clinic
- Results first posted
- 2018-10-26
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00524472?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00524472-3193d1fe